Gsa Capital Partners LLP Zomedica Corp. Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2024
A detailed history of Gsa Capital Partners LLP transactions in Zomedica Corp. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 2,995,874 shares of ZOM stock, worth $389,463. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,995,874
Previous 244,987
1122.87%
Holding current value
$389,463
Previous $36,000
1116.67%
% of portfolio
0.03%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ZOM
# of Institutions
97Shares Held
84.1MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA48.3MShares$6.28 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.86MShares$1.28 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA9.61MShares$1.25 Million0.0% of portfolio
-
State Street Corp Boston, MA3.51MShares$456,2840.0% of portfolio
-
Brown Brothers Harriman & CO New York, NY2.47MShares$320,6490.0% of portfolio
About Zomedica Corp.
- Ticker ZOM
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 979,950,016
- Market Cap $127M
- Description
- Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...